Life science industry shifts, such as new technologies, diseases, value drivers, and payers, are changing the landscape of value strategy. Cross-functional collaboration is crucial. This session discusses how to develop a cohesive strategy, who should be involved, and potential pitfalls to avoid. The session also explores differences in strategy between recent launch case studies.